Rueb Yuliya received 2,925 Tyra Biosciences shares at $9.13 each, lifting the reported holding to 11,258 shares. The award matters to investors because it changes the disclosed ownership position and represents about 26.0% of the resulting holding, with the transaction classified under code A.

Key Highlights

  • Rueb Yuliya’s reported Tyra Biosciences holding rose to 11,258 shares after the award.
  • The transaction covered 2,925 shares priced at $9.13 per share.
  • The award represented about 26.0% of Yuliya’s resulting share holding.

Rueb Yuliya received 2,925 shares of Tyra Biosciences, Inc. (NASDAQ: TYRA) at $9.13 per share on 15 September 2026. The award left Yuliya with 11,258 Tyra Biosciences shares, while the transaction represented about 26.0% of the resulting holding.

Award Adds to Yuliya’s Reported Position

The transaction date was 15 September 2026. Yuliya’s resulting ownership was 11,258 shares. The 2,925-share award accounted for about 26.0% of that resulting position. The reported ownership figure covers the holding after the award. Rueb Yuliya is identified in the source as Vice President, Finance (PAO) of Tyra Biosciences, Inc.